PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBApproximately 300,000 patients in the US will be eligible for the therapy. Roche’s Genentech acquires Regor Pharmaceuticals’ CDK inhibitors for $850m upfront. J&J and Legend share long-term results for Carvykti in phase 3 multiple myeloma study. Bristol Myers Squibb announces positive data for Sotyktu in moderate-to-severe psoriasis.
Communique - PMLiVE
WEBCommuniqué – Volume 53. New insights in health comms innovation. Communiqué Awards 2022 – winners’ case studies. INSIGHTS – Demonstrating impact • Driving behaviour change.
BOLDSCIENCE - PMLiVE
WEBWe are inspired by our vision to improve lives – for patients, our clients, and the people who work with us. BOLDSCIENCE is part of CO-LAB GLOBAL INC. Location. Areas of Expertise. Non-promotional medical communications services including: Clinical trial planning and recruitment support activities. Promotional medical communications services ...
Eli Lilly increases investment to almost $1bn for new Irish ...
WEBMar 29, 2023 · Eli Lilly has said it will be doubling the planned investment in its new biologics manufacturing facility in Ireland, bringing the total spend up to almost $1bn. The company originally announced its plans to build the Limerick-based facility in January 2022, which it anticipates will be its ‘most technically advanced manufacturing site to ...
Pfizer’s pentavalent meningococcal vaccine granted FDA approval
WEBOct 23, 2023 · Pfizer’s Penbraya has been approved by the US Food and Drug Administration (FDA) as the first pentavalent vaccine that provides protection against the five most common serogroups causing meningococcal disease in individuals aged ten to 25 years. Meningococcal disease is an uncommon but serious illness that can lead to death within 24 hours ...
FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis
WEBDec 24, 2019 · FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis. The FDA has approved the first two generics of Pfizer and Bristol-Myers Squibb’s blockbuster anticoagulant drug Eliquis, from Micro Labs and Mylan. FDA approval doesn’t necessarily mean that the generics will be made available anytime soon, …
This month in 1989: the creation of Bristol-Myers Squibb
WEBJul 29, 2014 · So far this year the pharma industry has not been short of speculation on potential mergers between some of the world’s biggest companies. The main story of interest has, of course, been Pfizer’s failed bid for AstraZeneca, although Valeant’s pursuit of Allergan and AbbVie’s attempts to take over Shire have also been consistently in …
Novartis and GSK complete oncology and vaccines swap
WEBMar 2, 2015 · Under the terms of the deal GSK is paying $5.25bn in case for Novartis’ vaccines business while Novartis is stumping up $16bn for GSK’s oncology business. The two companies are also pooling their resources in consumer health, creating a joint venture that will be 63.5% owned by GSK. Details of the asset swap were first revealed last April.
Gilead gets ‘gold’ in England’s hepatitis C eradication drive
WEBApr 30, 2019 · The deal reflects NHS England’s growing control over market access for specialised medicines in England, and it’s thought that it has succeeded in driving down the costs of the drug from £35,000 to just £10,000 per patient. The programme will include two Gilead hep C drugs at discounted prices: Harvoni and Epclusa, the latter being a ...
GSK survey results highlight meningitis knowledge gaps among …
WEBOct 13, 2023 · GSK has announced results from a survey revealing that parents are less knowledgeable about meningitis compared to other childhood infectious diseases. The multi-country GSK-commissioned and funded survey conducted by Ipsos revealed that 72% of over 4,000 parents said they were somewhat knowledgeable or knew …